Clinical Trial of Bilhvax,a Vaccine Candidate Against Schistosomiasis

Clinical trial NCT01512277 · COMPLETED

Trial details

NCT number: NCT01512277
Sponsor: University Hospital, Lille
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Schistosomiasis Bilharziasis Urinary Schistosomiasis

Start date: 1998-09-01
Primary completion: 1999-03-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.